How will DocMorris use the proceeds from the new bonds?

DocMorris said the proceeds will be used to fund the early buyback of its outstanding CHF 87.6 million 2026 convertible bond and for general corporate purposes outside of Switzerland.

What are the main terms of DocMorris's new convertible bonds?

The new bonds have a denomination of CHF 200,000 each, will be issued at par and carry a coupon of 3.00% per annum payable semi-annually in arrear. Unless previously converted, redeemed or repurchased and cancelled, they are expected to be redeemed at par on 24 August 2028.

What is the conversion price for DocMorris's new bonds?

The new bonds have an initial conversion price of CHF 6.54. DocMorris said this was set at a premium of 20% over the reference share price of CHF 5.45, which was the placement price per DocMorris share in the Concurrent Delta Placement.

What is DocMorris's planned tender offer for the 2026 convertible bonds?

DocMorris invited eligible holders of its outstanding CHF 87.6 million 2026 convertible bond to tender their bonds for cash during the planned Tender Offer period. The expected purchase price is CHF 1,035 per bond, corresponding to 103.5% of the par value, plus accrued and unpaid interest.

When will DocMorris's planned tender offer take place?

The expected cooling-off period for DocMorris's Tender Offer runs from 23 October 2025 to 5 November 2025, followed by the Tender Offer period from 6 November 2025 until 12 November 2025 at 4:00pm CET. The planned Tender Offer is solely made based on publication of the Tender Offer notice on 22 October 2025, and its expected settlement and payment date is 17 November 2025.

Is DocMorris's tender offer separate from the new bond offering?

Yes, DocMorris said the Tender Offer is executed independently and unconditionally from the New Bond Offering. The press release itself is not an offer for the repurchase of the 2026 Bonds and only discloses the most important terms of the planned Tender Offer.

Can the size of DocMorris's new bond issue be reduced?

Yes, the provisional allocation of the new bonds is subject to a pro-rata reduction of the issue size relative to the aggregate principal amount of bonds tendered under the Tender Offer. DocMorris refers to this potential reduction as the “Clawback”, with definitive allocations expected after the end of the Tender Offer period.

What was the Concurrent Delta Placement involving DocMorris shares?

The Joint Bookrunners organised a simultaneous placement of existing DocMorris shares on behalf of buyers of the new bonds who wished to sell shares in short sales to hedge the market risk of an investment in the new bonds. DocMorris will not receive any proceeds from the Concurrent Delta Placement.

What restrictions apply to DocMorris's new bond offering?

The New Bond Offering is being conducted solely on a private placement basis to professional clients in Switzerland and by private offering outside Switzerland pursuant to RegS (Category 1), with no Rule 144A. The announcement also states that the securities are not being publicly offered outside Switzerland and that distribution may be restricted in certain jurisdictions.

What lock-up has DocMorris agreed to in connection with the new bonds?

The Issuer and DocMorris agreed to a lock-up period starting from the pricing date and ending 90 days following the settlement date. The lock-up is subject to customary exceptions.

What does DocMorris do and where are its shares listed?

DocMorris is a Swiss-based company operating in online pharmacy, telemedicine and marketplace activities, with strong brands in Germany and other European countries. Its shares are listed on the SIX Swiss Exchange under securities number 4261528, ISIN CH0042615283 and ticker DOCM.

What future dates has DocMorris published for its reporting and shareholder events?

DocMorris has scheduled Sales 2025 for 20 January 2026, 2025 Full-year results and outlook 2026 for 19 March 2026, a Q1/2026 Trading update for 16 April 2026 and its Annual General Meeting in Zurich for 12 May 2026.

Home
News Intelligence
DocMorris AG
DocMorris completes CHF 49.6 million convertible bond placement

Back to all DocMorris AG press releases

DocMorris AG

SIX:DOCM

DocMorris completes CHF 49.6 million convertible bond placement

Published Wednesday, 22 October 2025, 05:00 AM

Get alerts

Plain English summaries when DocMorris AG announces news.

At a glance

Company: DocMorris AG
Listings: SIX:DOCM
Announcement type: Financing
Published: Wednesday, 22 October 2025, 05:00 AM
Source announcement: eqs-news.com

Key figures
Measure	Figure
Senior unsecured bonds due 2028	CHF 49.6 million
Outstanding Convertible Bonds due 2026	CHF 87.6 million
Tender Offer purchase price	CHF 1,035 per bond
Denomination	CHF 200,000 each
Coupon	3.00% per annum
Initial conversion price	CHF 6.54

Figures are quoted from this announcement and selected automatically.

FAQSIR Generated from this announcement View original release below for safe harbor and regulatory notices

Announcement Summary

DocMorris AG (ticker DOCM) completed a bond offering through DocMorris Finance B.V. and outlined a planned tender offer.

DocMorris Finance B.V. completed CHF 49.6 million of senior unsecured bonds due 2028, guaranteed by DocMorris AG and convertible into its shares.
Proceeds will fund the early buyback of CHF 87.6 million Outstanding Convertible Bonds due 2026 and general corporate purposes outside Switzerland.
Tender Offer is independent and unconditional; price expected CHF 1,035 per bond, or 103.5% of par value, plus accrued and unpaid interest.
Expected cooling-off: 23 October 2025 to 5 November 2025; Tender Offer: 6 November 2025 to 12 November 2025, ending 4:00pm CET.
New Bonds have CHF 200,000 denomination, 3.00% coupon, CHF 6.54 initial conversion price, and expected maturity on 24 August 2028.

Allocations face pro-rata reduction from tendered bonds; final allocations are expected after the tender period. Placement was private for Swiss professional clients and under RegS Category 1 outside Switzerland, with no Rule 144A.

Investor FAQs

DocMorris announced that DocMorris Finance B.V., its directly wholly-owned subsidiary, had successfully completed the offering of CHF 49.6 million senior unsecured bonds due 2028. The bonds are guaranteed by DocMorris AG and are convertible into newly issued and/or existing registered shares of the Company.

Source announcement

Company: DocMorris AG
Title: DocMorris successfully completes the placement of CHF 49.6 million Convertible Bonds due 2028
Published: Wednesday, 22 October 2025, 05:00 AM
Source site: eqs-news.com

Read the source announcement on eqs-news.com

FAQSIR's summary and investor FAQs are generated by AI from the text of this announcement alone, without information from other sources.

Figures, forecasts and other claims are the announcement's, not FAQSIR's. FAQSIR does not independently verify them.

Read the original press release

Full text as published, unedited.

Loading the original release…

Important Notice And Disclaimer

This article was generated by an artificial intelligence system from an announcement published by the issuer. It has not been independently researched, verified, or edited by a journalist, and no person holds editorial responsibility for its wording.

The issuer named in this article has not paid for this page and has no commercial relationship with its publisher. This is an unpaid evaluation preview produced from announcements the issuer published publicly, and it is not independent editorial coverage.

This article does not provide any financial advice and is not a recommendation to deal in any securities or product. Investments may fall in value and an investor may lose some or all of their investment. Past performance is not an indicator of future performance.

Ask about this announcement

Answers drawn only from this announcement

Reading the announcement…